Pathol. Int. 2020 Jan 30
A rare case of congenital spindle cell rhabdomyosarcoma with TEAD1-NCOA2 fusion: A subset of spindle cell rhabdomyosarcoma with indolent behavior.
Tan GZL, Saminathan SN, Chang KTE, Odoño EG, Kuick CH, Chen H, Lee VKM
Read More
Source: PubMed
Acta Chir. Belg. 2020 Jan 29
Successful outcome following resection of metachronous pancreatic metastasis from a rhabdomyosarcoma.
Monge M, Chiavelli H, Pinson J, Papet E, Schwarz L, Tuech JJ
Background: Pancreatic metastases (PM) are rare, comprising 3% of pancreatic tumours removed in sizable series of operations. This report presents the ...
Read More
Source: PubMed
Pediatr Blood Cancer 2020 Jan 28
An unresolved issue in rhabdomyosarcoma treatment: The duration of chemotherapy.
Bisogno G, Hawkins DS
Clinical trials have tested different chemotherapy regimens to improve outcome for patients with rhabdomyosarcoma (RMS), but therapy duration has neve ...
Read More
Source: PubMed
Am. J. Surg. Pathol. 2020 Jan 27
Embryonal Rhabdomyosarcoma of the Ovary and Fallopian Tube: Rare Neoplasms Associated With Germline and Somatic DICER1 Mutations.
McCluggage WG, Apellaniz-Ruiz M, Chong AL, Hanley KZ, Velázquez Vega JE, McVeigh TP, Foulkes WD
DICER1 mutations (somatic or germline) are associated with a variety of uncommon neoplasms including cervical and genitourinary embryonal rhabdomyosar ...
Read More
Source: PubMed
Cancer Metastasis Rev. 2020 Jan 27
Signaling pathways in Rhabdomyosarcoma invasion and metastasis.
Ramadan F, Fahs A, Ghayad SE, Saab R
Rhabdomyosarcoma (RMS) is an aggressive childhood mesenchymal tumor with two major molecular and histopathologic subtypes: fusion-positive (FP)RMS, ch ...
Read More
Source: PubMed
